...
首页> 外文期刊>Surgery >Use of a temporary intraoperative mesentericoportal shunt for pancreatic resection for locally advanced pancreatic cancer with portal vein occlusion and portal hypertension
【24h】

Use of a temporary intraoperative mesentericoportal shunt for pancreatic resection for locally advanced pancreatic cancer with portal vein occlusion and portal hypertension

机译:术中临时性肠系膜门分流术在局部晚期胰腺癌合并门静脉阻塞和门静脉高压症中的应用

获取原文
获取原文并翻译 | 示例
           

摘要

Background Our aim was to evaluate the perioperative morbidity and survival of a selected group of patients with locally advanced pancreatic ductal adenocarcinoma (PDAC) and malignant obstruction of portal axis inducing portal hypertension (PH) who underwent a curative intent pancreatic resection, after neoadjuvant chemotherapy, adopting a new type of temporary intraoperative mesentericoportal shunt (TMPS). Methods We analyzed the perioperative data and survival outcome of 15 patients with locally advanced PDAC and PH who underwent pancreatoduodenectomy combined with vascular resections between October 2008 and October 2012 using this TMPS. Results There was no perioperative mortality. Postoperative morbidity occurred in 7 patients without any postoperative liver failure. All patients underwent mesentericoportal venous resection, 11 of whom had a concomitant arterial resection. The mean ± SD follow-up was 16 ± 10 months (range, 4-40; median 15). Overall survival rates of patients were 78% and 11% at 1 and at 3 years, respectively. Median survival was 17 months. The 1-year disease-free survival was 36%. Conclusion The use of this form of TMPS allowed us to achieve PD or total pancreatectomy in patients with locally advanced PDAC and PH without postoperative mortality but with increased morbidity. The relevance of such an aggressive approach is yet to be determined.
机译:背景:我们的目的是评估一组选择的局部晚期胰腺导管腺癌(PDAC)和恶性梗阻门轴诱发门脉高压(PH)的患者的围手术期发病率和存活率,这些患者在新辅助化疗后进行了治愈性胰腺切除术,采用新型的临时术中肠系膜分流术(TMPS)。方法我们分析了2008年10月至2012年10月间使用胰十二指肠切除术并进行血管切除术的15例局部晚期PDAC和PH患者的围手术期数据和生存结果。结果无围手术期死亡。 7例患者发生了术后发病,无术后肝功能衰竭。所有患者均接受了肠系膜门静脉切除术,其中11例同时进行了动脉切除术。平均±SD随访时间为16±10个月(范围4-40;中位数15)。患者在1年和3年时的总生存率分别为78%和11%。中位生存期为17个月。 1年无病生存率为36%。结论这种形式的TMPS的使用使我们能够在局部晚期PDAC和PH的患者中实现PD或全胰腺切除术,而无术后死亡率,但发病率增加。这种激进方法的相关性尚待确定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号